The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection
Open accessAbstract
RNA interference (RNAi)-based therapeutics have the potential to treat chronic hepatitis B virus (HBV) infection in a fundamentally different manner than current therapies. Using RNAi, it is possible to knock down expression of viral RNAs including the pregenomic RNA from which the replicative intermediates are derived, thus reducing viral load, and the viral proteins that result in disease and impact the immune system's ability to eliminate the virus. We previously described the use of polymer-based Dynamic PolyConjugate (DPC) for the targeted delivery of siRNAs to hepatocytes. Here, we first show in proof-of-concept studies that simple coinjection of a hepatocyte-targeted, N-acetylgalactosamine-conjugated melittin-like peptide (NAG-MLP) with a liver-tropic cholesterol-conjugated siRNA (chol-siRNA) targeting coagulation factor VII (F7) results in efficient F7 knockdown in mice and nonhuman primates without changes in clinical chemistry or induction of cytokines. Using transient and transgenic mouse models of HBV infection, we show that a single coinjection of NAG-MLP with potent chol-siRNAs targeting conserved HBV sequences resulted in multilog repression of viral RNA, proteins, and viral DNA with long duration of effect. These results suggest that coinjection of NAG-MLP and chol-siHBVs holds great promise as a new therapeutic for patients chronically infected with HBV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Self-citationLee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
THE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSES
Ganem, D., & Varmus, H. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003251 · Cited by 1,084
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli
Galibert, F., Mandart, E., Fitoussi, F., Tiollais, P., & Charnay, P. (1979) · Nature · doi:10.1038/281646a0 · Cited by 981
Zhang, G., Budker, V., & Wolff, J. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950017734 · Cited by 944
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
Rozema, D. B., Lewis, D. L., Wakefield, D. H., Wong, S. C., Klein, J. J., Roesch, P. L., Bertin, S. L., Reppen, T. W., Chu, Q., Blokhin, A. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703778104 · Cited by 658
Self-citationHigh-level hepatitis B virus replication in transgenic mice
Guidotti, L. G., Matzke, B., Schaller, H., & Chisari, F. V. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6158-6169.1995 · Cited by 642
Inhibition of hepatitis B virus in mice by RNA interference
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., Xu, H., Wieland, S. F., Marion, P. L., & Kay, M. A. (2003) · Nature Biotechnology · doi:10.1038/nbt824 · Cited by 607
Ferrari, C., Penna, A., Bertoletti, A., Valli, A., Antoni, A. D., Giuberti, T., Cavalli, A., Petit, M. A., & Fiaccadori, F. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3442 · Cited by 505
Beck, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.48 · Cited by 494
Moucari, R., Mackiewicz, V., Lada, O., Ripault, M.-P., Castelnau, C., Martinot-Peignoux, M., Dauvergne, A., Asselah, T., Boyer, N., Bedossa, P., et al. (2009) · Hepatology · doi:10.1002/hep.22744 · Cited by 468
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
Heathcote, E. J., Marcellin, P., Buti, M., Gane, E., De Man, R. A., Krastev, Z., Germanidis, G., Lee, S. S., Flisiak, R., Kaita, K., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.011 · Cited by 462
Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection
Yang, P. L., Althage, A., Chung, J., & Chisari, F. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202398599 · Cited by 380
Sabath, D. E., Broome, H. E., & Prystowsky, M. B. (1990) · Gene · doi:10.1016/0378-1119(90)90087-8 · Cited by 377
Funk, M. L., Rosenberg, D. M., & Lok, A. S. F. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00304.x · Cited by 354
Chen, J., Yang, H., Iloeje, U. H., You, S., Lu, S., Wang, L., Su, J., Sun, C., Liaw, Y., & Chen, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.042 · Cited by 331
Small interfering RNA Inhibits Hepatitis B virus replication in mice
Giladi, H., Ketzinel-Gilad, M., Rivkin, L., Felig, Y., Nussbaum, O., & Galun, E. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00244-2 · Cited by 306
Chisari, F. V., Filippi, P., McLachlan, A., Milich, D. R., Riggs, M., Lee, S., Palmiter, R. D., Pinkert, C. A., & Brinster, R. L. (1986) · Journal of Virology · doi:10.1128/jvi.60.3.880-887.1986 · Cited by 269
Self-citationBertoletti, A., Costanzo, A., Chisari, F. V., Levrero, M., Artini, M., Sette, A., Penna, A., Giuberti, T., Fiaccadori, F., & Ferrari, C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.933 · Cited by 226
Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs
Uprichard, S. L., Boyd, B., Althage, A., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409028102 · Cited by 198
Grimm, D., Wang, L., Lee, J. S., Schürmann, N., Gu, S., Börner, K., Storm, T. A., & Kay, M. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43565 · Cited by 196
Targeting hepatocytes for drug and gene delivery emerging novel approaches and applications
Wu, J. (2002) · Frontiers in Bioscience · doi:10.2741/a806 · Cited by 190
Tang, H., & McLachlan, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1841 · Cited by 183
Self-citationMoucari, R., Korevaar, A., Lada, O., Martinot-Peignoux, M., Boyer, N., Mackiewicz, V., Dauvergne, A., Cardoso, A. C., Asselah, T., Nicolas-Chanoine, M.-H., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.01.016 · Cited by 182
Barnaba, V, Franco, A., Alberti, A., Balsano, C., Benvenuto, R., & Balsano, F. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2650 · Cited by 166
Treatment of chronic hepatitis B: Evolution over two decades
Yuen, M., & Lai, C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06545.x · Cited by 164
Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B
Jung, M.-C., Spengler, U., Schraut, W., Hoffmann, R., Zachoval, R., Eisenburg, J., Eichenlaub, D., Riethmüller, G., Paumgartner, G., Ziegler-Heitbrock, H. W. L., et al. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90074-l · Cited by 162
Endosomolysis by Masking of a Membrane-Active Agent (EMMA) for Cytoplasmic Release of Macromolecules
Rozema, D. B., Ekena, K., Lewis, D. L., Loomis, A. G., & Wolff, J. A. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0255945 · Cited by 161
Self-citationSuppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs
Sioud, M., Furset, G., & Cekaite, L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.177 · Cited by 151
Nassal, M., Junker-Niepmann, M., & Schaller, H. (1990) · Cell · doi:10.1016/0092-8674(90)90431-d · Cited by 144
Gish, R. G., Chang, T., Lai, C., de Man, R., Gadano, A. C., Poordad, F. F., Yang, J., Brett‐Smith, H., & Tamez, R. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01146.x · Cited by 142
RNAi for Treating Hepatitis B Viral Infection
Chen, Y., Cheng, G., & Mahato, R. I. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9504-0 · Cited by 130
Carmona, S., Jorgensen, M. R., Kolli, S., Crowther, C. E., Salazar, F. H., Marion, P. L., Fujino, M., Natori, Y., Thanou, M., Arbuthnot, P. B., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800157x · Cited by 127
Guidotti, L., Martinez, V., Loh, Y.-T., Rogler, C. E., & Chisari, F. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5469-5475.1994 · Cited by 115
Wong, S. C., Klein, J. J., Hamilton, H., Chu, Q., Frey, C. L., Trubetskoy, V. S., Hegge, J., Wakefield, D. H., Rozema, D. B., & Lewis, D. L. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0389 · Cited by 101
Self-citationMinicircle DNA electrotransfer for efficient tissue-targeted gene delivery
Chabot, S., Orio, J., Schmeer, M., Schleef, M., Golzio, M., & Teissié, J. (2012) · Gene Therapy · doi:10.1038/gt.2011.215 · Cited by 75
Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs
Huang, H., Qiao, R., Zhao, D., Zhang, T., Li, Y., Fan, Y., Lai, F., Hong, J., Ding, X., Yang, Z., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp835 · Cited by 60
Long-term RNA interference from optimized siRNA expression constructs in adult mice
Wooddell, C. I., Hout, C. V. V., Reppen, T., Lewis, D. L., & Herweijer, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.066 · Cited by 28
Self-citationConstitutive Expression of Short Hairpin RNA in Vivo Triggers Buildup of Mature Hairpin Molecules
Ahn, M., Witting, S. R., Ruiz, R., Saxena, R., & Morral, N. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.234 · Cited by 14
Cited by
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Metadata
- Authors
- Wooddell, C. I., Rozema, D. B., Hossbach, M., John, M., Hamilton, H. L., Chu, Q., Hegge, J. O., Klein, J. J., Wakefield, D. H., Oropeza, C. E., Deckert, J., Roehl, I., Jahn-Hofmann, K., Hadwiger, P., Vornlocher, H.-P., McLachlan, A., & Lewis, D. L.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 21
- Issue
- 5
- Pages
- 973-985
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2023843484
- Cited by
- 293
- References
- 46
- FWCI
- 19.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.